INFORMATION

In order to receive credit for this enduring material, participants must:
● Score at least 70% on this exam
● Include their name and contact information at the bottom of this page

Please answer the questions by choosing the appropriate rating/answer or filling in the box

Approximately ______ of adults in the US have elevated TG levels (≥150 mg/dL)

Question Title

* 1. Approximately ______ of adults in the US have elevated TG levels (≥150 mg/dL)

Based on ATP III treatment recommendations for elevated TGs, which of the following ranges is considered “high,” prompting consideration of drug therapy to achieve non-HDL-C goal in non-diabetic persons?

Question Title

* 2. Based on ATP III treatment recommendations for elevated TGs, which of the following ranges is considered “high,” prompting consideration of drug therapy to achieve non-HDL-C goal in non-diabetic persons?

Why is it important to measure non-HDL-C in patients with hypertriglyceridemia (HTG)?

Question Title

* 3. Why is it important to measure non-HDL-C in patients with hypertriglyceridemia (HTG)?

Which of the following statements is true?

Question Title

* 4. Which of the following statements is true?

The Non-HDL-C treatment goal for patients with diabetes, according to the ADA/ACC Treatment Goals in Patients with Cardiometabolic Risk, is:

Question Title

* 5. The Non-HDL-C treatment goal for patients with diabetes, according to the ADA/ACC Treatment Goals in Patients with Cardiometabolic Risk, is:

Of these trials: ACCORD, AIM-HIGH, FIELD, and HPS2-THRIVE, which had a positive primary endpoint?

Question Title

* 6. Of these trials: ACCORD, AIM-HIGH, FIELD, and HPS2-THRIVE, which had a positive primary endpoint?

Which of the following statements is true?

Question Title

* 7. Which of the following statements is true?

Atherogenic consequences of HTG do not include:

Question Title

* 8. Atherogenic consequences of HTG do not include:

Which of the following is not a common secondary cause of HTG?

Question Title

* 9. Which of the following is not a common secondary cause of HTG?

Which of the following is not true, according to NHANES data?

Question Title

* 10. Which of the following is not true, according to NHANES data?

The next few questions are required for receipt of a CME certificate.
What is your First and Last Name?

Question Title

* 11. What is your First and Last Name?

What is your degree?

Question Title

* 12. What is your degree?

What is your email address? (for CME certificate)

Question Title

* 13. What is your email address? (for CME certificate)

If you score 70% or above on this test, you will receive a CME certificate via email within 4-6 weeks.
If you score below 70%, you may re-take the test.

Please contact Pamela Clark if you have questions or concerns at pclark@medtelligence.net.

Thank you for your interest in our programs!


*Requires an answer.

(ACC=American College of Cardiology; ACCORD=Action to Control Cardiovascular Risk in Diabetes; ADA=American Diabetes Association; AHA=American Heart Association; AIM-HIGH=Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes; Apo=apolipoprotein; ATP=Adult Treatment Panel; BMI=body mass index; CHD=coronary heart disease; CVD=cardiovascular disease; DHA=docosahexaenoic acid; EPA= eicosapentaenoic acid; FIELD=Fenofibrate Intervention and Event Lowering in Diabetes; HDL-C=high-density lipoprotein cholesterol; HPS2-THRIVE=Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events; HTG=hypertriglyceridemia; LDL=low-density lipoprotein; LDL-C=LDL cholesterol; NHANES=National Health and Nutrition Examination Survey; TG=triglyceride; VLDL-C=very-low-density lipoprotein cholesterol.)

T